What is the delivery time?

Delivery time is typically 1-7 days from the place of origin.

Can I customize the product packaging?

Yes, OEM and ODM services are available for this product.

What are the accepted payment methods?

We accept T/T, PayPal, and Western Union.

Feline Panleukopenia Virus Rapid Test

Name: Feline Panleukopenia Virus Rapid Test
Brand: Auker Biotech Co., Ltd.
SKU: 1971089281

Hubei, ChinaAuker Biotech Co., Ltd.

Negotiable

100 Pieces

Product profile

Customization

Available

Type

IVD Reagent

place of origin

China

Model NO.

FPV

MOQ

20box

OEM/ODM

Available

delivery time

1-7days

payment method

T/T, paypal

Transport Package

10test/Box, 50box/Carton

Specification

10test/box

Trademark

sunpet

Origin

China

HS Code

3822190010

Production Capacity

100000/Month

Key features

Rapid Detection Time: Provides results in just 5-10 minutes for quick diagnosis.

High Accuracy Rate: Delivers 98.8% accurate results for reliable Feline Parvovirus screening.

Easy Home Testing: Designed for convenient at-home use, eliminating the need for vet visits.

Non-Invasive Sample: Uses simple swabs from feces or vomit for a stress-free experience.

Complete Kit Included: Contains test devices, buffer, swabs, and manual; no extra purchases needed.

OEM/ODM Available: Customization services are available for bulk orders.

Flexible Delivery: Fast delivery within 1-7 days from Wuhan, China.

Multiple Payment Options: Accepts T/T, PayPal, and Western Union for secure transactions.

Company profile

Auker Biotech Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-04-30Nearest Port: Wuhan, ShanghaiAverage Response Time: ≤15hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryAuker Biotech Co., Ltd. is a China-based limited company and factory/trading company located in Wuhan, Hubei. It specializes in in-vitro diagnostic raw materials, including antigens, antibodies, recombinant proteins, and related customized services. The supplier reports ISO 9001 and ISO 13485 certifications, two technology platforms, three production lines, dedicated R&D and quality-control personnel, and export activity across multiple global regions. It has self-operated import/export rights and reports order fulfillment within 15 working days in both peak and off-peak periods. Evidence supports established technical, certification, production, and export capabilities. However, the provided information does not sufficiently establish after-sales service practices, financial credibility, or verified customer case depth. The trade record shows only two transactions and one associated buyer name, so customer experience evidence remains limited.

Supplier typeThe supplier is identified as a factory, manufacturer/trading company, and limited company based in Wuhan, China. Its stated business focuses on R&D, production, and sales of in-vitro diagnostic raw materials, including antigens, antibodies, and recombinant proteins.

CertificationsThe supplier reports ISO 9001 and ISO 13485 quality system certifications. These certifications provide explicit evidence of formal quality-management and medical-device-related management systems.

R&D capabilityThe company states that it was established in 2002, operates a mouse monoclonal antibody hybridoma platform and a recombinant protein expression platform, and is recognized as a high-tech enterprise with several innovation-related honors. These details explicitly support established R&D and innovation capability.

Production capacityThe supplier reports production of in-vitro diagnostic raw materials, three production lines, operation of a colloidal gold and fluorescence chromatography large-plate production line since 2021, and order fulfillment within 15 working days in both peak and off-peak seasons. This supports active and reasonably responsive production capability.

Customization capabilityThe company explicitly states that it provides customized services for monoclonal antibodies, multi-antibodies, and recombinant proteins. This is direct evidence of customization capability in its core product categories.